CLOBETASOL PROPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Clobetasol Propionate patents expire, and when can generic versions of Clobetasol Propionate launch?
Clobetasol Propionate is a drug marketed by Alembic, Glenmark Pharms Ltd, Novast Labs, Padagis Israel, Taro, Amneal, Aurobindo Pharma Usa, Chartwell Rx, Cosette, Encube, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Pai Holdings Pharm, Rising, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Padagis Us, Actavis Mid Atlantic, Epic Pharma Llc, Zydus Lifesciences, Macleods Pharms Ltd, Novel Labs Inc, Hikma, Prinston Inc, Quagen, Saptalis Pharms, Wockhardt Bio Ag, Akorn, Apotex, and Ani Pharms. and is included in seventy-nine NDAs.
The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clobetasol Propionate
A generic version of CLOBETASOL PROPIONATE was approved as clobetasol propionate by COSETTE on February 16th, 1994.
Summary for CLOBETASOL PROPIONATE
US Patents: | 0 |
Applicants: | 34 |
NDAs: | 79 |
Finished Product Suppliers / Packagers: | 36 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 66 |
Patent Applications: | 4,524 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CLOBETASOL PROPIONATE |
Drug Sales Revenues: | Drug sales revenues for CLOBETASOL PROPIONATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CLOBETASOL PROPIONATE |
What excipients (inactive ingredients) are in CLOBETASOL PROPIONATE? | CLOBETASOL PROPIONATE excipients list |
DailyMed Link: | CLOBETASOL PROPIONATE at DailyMed |
Recent Clinical Trials for CLOBETASOL PROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GEN İlaç ve Sağlık Ürünleri A.Ş. | Phase 2 |
Monitor CRO | Phase 2 |
Combined Military Hospital Abbottabad | Phase 1 |
Pharmacology for CLOBETASOL PROPIONATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE
Anatomical Therapeutic Chemical (ATC) Classes for CLOBETASOL PROPIONATE
Paragraph IV (Patent) Challenges for CLOBETASOL PROPIONATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
IMPOYZ | Cream | clobetasol propionate | 0.025% | 209483 | 1 | 2019-12-06 |
OLUX E | Emulsion Foam | clobetasol propionate | 0.05% | 022013 | 1 | 2010-02-25 |
CLOBEX | Spray | clobetasol propionate | 0.05% | 021835 | 1 | 2008-09-29 |
CLOBEX | Topical Shampoo | clobetasol propionate | 0.05% | 021644 | 1 | 2008-01-09 |
CLOBEX | Lotion | clobetasol propionate | 0.05% | 021535 | 1 | 2006-03-27 |
OLUX | Topical Foam | clobetasol propionate | 0.05% | 021142 | 1 | 2005-06-27 |